Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19.

ABSTRACT: We presented the clinical course and immune responses of a well-controlled HIV-positive patient with COVID-19. The clinical presentation and antibody production to SARS-CoV-2 were similar to other COVID-19 patients without HIV infection. Neutralizing antibody reached a plateau from 26th to 47th day onset but decreased on 157th day after symptoms.

SUBMITTER: Liu WD 

PROVIDER: S-EPMC8059939 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature